Andrew Clair is Director and Team Leader, CNS Products, Pfizer Pharmaceuticals Group, Regulatory Affairs, at Pfizer Inc., where he is responsible for regulatory maintenance of marketed products. He directs activities relating to US and worldwide regulatory matters, including regulatory chemistry, manufacturing and controls and clinical trial submissions, labeling, and approval of promotional materials. Dr. Clair has over 20 years of industry regulatory experience and has dealt with FDA on Drug Master Files, INDs, NDAs and ANDAs. He was an adjunct professor at St. John’s University, lecturing on regulatory aspects of drug production and distribution. He has also lectured about liaison activities with FDA at the Center for Professional Advancement. His PhD in Pharmacology is from St. John’s, and he has nine research publications.

Return to Faculty Home